300171 Stock Overview
Tofflon Science and Technology Group Co., Ltd.
Tofflon Science and Technology Group Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||CN¥28.39|
|52 Week High||CN¥68.00|
|52 Week Low||CN¥26.18|
|1 Month Change||-8.27%|
|3 Month Change||-12.57%|
|1 Year Change||-46.54%|
|3 Year Change||281.59%|
|5 Year Change||156.69%|
|Change since IPO||154.28%|
Recent News & Updates
|300171||CN Medical Equipment||CN Market|
Return vs Industry: 300171 underperformed the CN Medical Equipment industry which returned -26.3% over the past year.
Return vs Market: 300171 underperformed the CN Market which returned -9.7% over the past year.
|300171 Average Weekly Movement||7.3%|
|Medical Equipment Industry Average Movement||5.6%|
|Market Average Movement||6.0%|
|10% most volatile stocks in CN Market||9.1%|
|10% least volatile stocks in CN Market||3.9%|
Stable Share Price: 300171 is not significantly more volatile than the rest of CN stocks over the past 3 months, typically moving +/- 7% a week.
Volatility Over Time: 300171's weekly volatility (7%) has been stable over the past year.
About the Company
Tofflon Science and Technology Group Co., Ltd. operates as a pharmaceutical equipment supplier for the pharma and biotech industries worldwide. It offers injectables, such as auto solution preparation systems, aseptic filling lines for ampoule, vials, syringes and powders, freeze dryer and auto loading systems, barrier systems, and plastic packaging machines.
Tofflon Science and Technology Group Fundamentals Summary
|300171 fundamental statistics|
Is 300171 overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|300171 income statement (TTM)|
|Cost of Revenue||CN¥2.62b|
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
|Earnings per share (EPS)||1.46|
|Net Profit Margin||19.71%|
How did 300171 perform over the long term?See historical performance and comparison
1.4%Current Dividend Yield
Is 300171 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 3/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 300171?
Other financial metrics that can be useful for relative valuation.
|What is 300171's n/a Ratio?|
Price to Earnings Ratio vs Peers
How does 300171's PE Ratio compare to its peers?
|300171 PE Ratio vs Peers|
|Company||PE||Estimated Growth||Market Cap|
300482 Guangzhou Wondfo BiotechLtd
002901 Double Medical Technology
300869 Contec Medical SystemsLtd
300171 Tofflon Science and Technology Group
Price-To-Earnings vs Peers: 300171 is good value based on its Price-To-Earnings Ratio (19.4x) compared to the peer average (47.3x).
Price to Earnings Ratio vs Industry
How does 300171's PE Ratio compare vs other companies in the CN Medical Equipment Industry?
Price-To-Earnings vs Industry: 300171 is good value based on its Price-To-Earnings Ratio (19.4x) compared to the CN Medical Equipment industry average (32.9x)
Price to Earnings Ratio vs Fair Ratio
What is 300171's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PE Ratio||19.4x|
|Fair PE Ratio||32.8x|
Price-To-Earnings vs Fair Ratio: 300171 is good value based on its Price-To-Earnings Ratio (19.4x) compared to the estimated Fair Price-To-Earnings Ratio (32.8x).
Share Price vs Fair Value
What is the Fair Price of 300171 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 300171 (CN¥28.39) is trading above our estimate of fair value (CN¥9.3)
Significantly Below Fair Value: 300171 is trading above our estimate of fair value.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
How is Tofflon Science and Technology Group forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?
Future Growth Score5/6
Future Growth Score 5/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 300171's forecast earnings growth (25.8% per year) is above the savings rate (3.2%).
Earnings vs Market: 300171's earnings (25.8% per year) are forecast to grow faster than the CN market (24.6% per year).
High Growth Earnings: 300171's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 300171's revenue (25.6% per year) is forecast to grow faster than the CN market (17.8% per year).
High Growth Revenue: 300171's revenue (25.6% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 300171's Return on Equity is forecast to be low in 3 years time (19.7%).
Discover growth companies
How has Tofflon Science and Technology Group performed over the past 5 years?
Past Performance Score5/6
Past Performance Score 5/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 300171 has a high level of non-cash earnings.
Growing Profit Margin: 300171's current net profit margins (19.7%) are higher than last year (18%).
Past Earnings Growth Analysis
Earnings Trend: 300171's earnings have grown significantly by 48.6% per year over the past 5 years.
Accelerating Growth: 300171's earnings growth over the past year (76.3%) exceeds its 5-year average (48.6% per year).
Earnings vs Industry: 300171 earnings growth over the past year (76.3%) exceeded the Medical Equipment industry 9.2%.
Return on Equity
High ROE: 300171's Return on Equity (20.8%) is considered high.
Discover strong past performing companies
How is Tofflon Science and Technology Group's financial position?
Financial Health Score6/6
Financial Health Score 6/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: 300171's short term assets (CN¥8.7B) exceed its short term liabilities (CN¥5.3B).
Long Term Liabilities: 300171's short term assets (CN¥8.7B) exceed its long term liabilities (CN¥108.8M).
Debt to Equity History and Analysis
Debt Level: 300171 is debt free.
Reducing Debt: 300171 has no debt compared to 5 years ago when its debt to equity ratio was 0.3%.
Debt Coverage: 300171 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 300171 has no debt, therefore coverage of interest payments is not a concern.
Discover healthy companies
What is Tofflon Science and Technology Group current dividend yield, its reliability and sustainability?
Dividend Score 4/6
Cash Flow Coverage
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: 300171's dividend (1.36%) is higher than the bottom 25% of dividend payers in the CN market (0.45%).
High Dividend: 300171's dividend (1.36%) is low compared to the top 25% of dividend payers in the CN market (1.88%).
Stability and Growth of Payments
Stable Dividend: 300171's dividend payments have been volatile in the past 10 years.
Growing Dividend: 300171's dividend payments have increased over the past 10 years.
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (26%), 300171's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonable cash payout ratio (57.5%), 300171's dividend payments are covered by cash flows.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Xiaodong Zheng (58 yo)
Mr. Xiao Dong Zheng has been Chairman and General Manager at Tofflon Science and Technology Group Co., Ltd. since March 18, 2014. Mr. Zheng served as General manager of Shanghai Tofflon Science and Technol...
Experienced Management: 300171's management team is seasoned and experienced (8.4 years average tenure).
Experienced Board: 300171's board of directors are considered experienced (8.4 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Tofflon Science and Technology Group Co., Ltd.'s employee growth, exchange listings and data sources
- Name: Tofflon Science and Technology Group Co., Ltd.
- Ticker: 300171
- Exchange: SZSE
- Founded: 1993
- Industry: Health Care Equipment
- Sector: Healthcare
- Implied Market Cap: CN¥18.039b
- Shares outstanding: 635.42m
- Website: https://www.tofflon.com
Number of Employees
- Tofflon Science and Technology Group Co., Ltd.
- 1509, Duhui Road
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/08/16 00:00|
|End of Day Share Price||2022/08/16 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.